NEOMED Library: PPC IV Literature Review Requirements (self-directed learning assignment): Oncology Topics

Breast cancer

Comparing trastuzumab to bevacizumab for the treatment of breast cancer
Zoledronate versus ibandronate for the treatment of breast cancer
Anastrozole versus tamoxifen for the treatment of breast cancer
Letrozole versus tamoxifen for treating breast cancer
Letrozole versus anastrozole for treating breast cancer
Comparing trastuzumab monotherapy to T-DM1 for second-line treatment of HER-2 positive breast cancer
PF005280014 (trastuzumab biosimilar) versus trastuzumab for breast cancers involving HER2+ expression
Feasibility and Safety of Arm vs. Chest Ports in Patients with Breast Cancer
Comparing ultrasonography and mammography to mammography alone for breast cancer screening
Comparing Exemestane to Tamoxifen in the Treatment of Premenopausal Breast Cancer

Laparotomy or laparoscopy in the treatment of high-risk endometrial cancer patients
Comparing laparoscopy to laparotomy as surgical treatment for cervical cancer
HPV screening versus pap test for cervical cancer screening
Laparoscopy versus laparotomy in treating endometrial cancer

Comparing gefitinib versus docetaxel in treating non-small-cell lung cancer
Comparing vorinostat/paclitaxel to paclitaxel alone for treating non-small-cell lung cancer
Comparing vorinostat/carboplatin to carboplatin alone for treating non-small-cell lung cancer
Comparing atezolizumab to docetaxel for patients for treating non-small-cell lung cancer
Comparing nivolumab to docetaxel for treating non-small-cell lung cancer
Comparing atezolizumab and docetaxel for treatment of non-small cell lung cancer
Collateral Sensitivity in ALK-rearranged Non-small Cell Lung Cancer
Paclitaxel/carboplatin and Paclitaxel/cisplatin: Advanced Non-Small Cell Lung Cancer Treatment
Durvalumab plus platinum (carboplatin or cisplatin)-etoposide treatment versus platinum-etoposide alone for treating extensive-stage small cell lung cancer (ES-SCLC)

Ipilimumab and sargramostim compared to ipilimumab for treating metastatic melanoma
Nivolumab vs ipilimumab for treating melanoma
Nivolumab vs Ipilimumab vs Nivolumab and Ipilimumab for treating advanced melanoma
Vemurafenib vs dabrafenib vs trametinib for treating metastatic melanoma

Denosumab versus zoledronic acid for treating bone metastases in advanced cancer
Comparing adjuvant sunitinib to sorafenib for treating non-metastatic renal-cell carcinoma
Temozolomide vs. Standard PCV for treating high-grade gliomas
Comparing the pain intensity and misconceptions among hospice patients with cancer and their caregivers
Eicosapentaenoic acid versus aspirin for the prevention of colorectal adenomas
Nilotinib versus imatinib for treating Philadelphia chromosome positive chronic myeloid leukemia
Comparing radical prostatectomy to watchful waiting for treating early prostate cancer
Computed virtual chromoendoscopy vs. conventional colonoscopy
Chimeric antigen receptor-modified T cells to treat leukemia. Special topic: see H. McEwen for help with article selection
Comparing cyclophosphamide to ifosfamide for treating soft tissue sarcoma
Recombinant poliovirus treatment of recurrent glioblastoma
Comparing the effectiveness of Colonoscopy and Fecal Immunochemical Testing for Colorectal-Cancer Screening
Gamma Knife vs Cyberknife Radiosurgical Techniques for Treating Secondary Neurological Neoplasm

Vemurafenib (formerly PLX4032) for treating metastatic melanoma. Find one randomized control trial comparing this drug to another drug. For your second article, find an article testing PLX4032 on cancer cell lines. Choose a review article of your choice.
Crizotinib for treating non-small cell lung cancer. See H. McEwen about the choosing your articles.